Editors
World's Second Human Trials of Embryonic Stem Cells May Make the Blind See Again
4/20/2009 11:00:00 AM
In what would be the second human trials of embryonic stem cells (the first for spinal cord injuries), a UK team is applying for regulatory approval from the Medicines and Healthcare products Regulatory Agency, the Human Tissue Authority, in order to replace damaged cells caused by age-related macular degeneration (AMD), the most common cause of blindness.
Embryonic stem cells will be re...
Editors
Horse Stem Cell Technique to be Tested on Humans
4/16/2009 9:00:00 AM
It's rare for veterinary medicine to lead human medicine, but race horses are a different breed. A stem cell technique that has been used to quickly repair the tendons of race horses will be tried in humans for the first time.
British biotech firm MedCell Bioscience Ltd said on Wednesday it would start clinical tests within 12 months to extract Mesenchymal adult stem cells from a patien...
Editors
Breakthrough?: British Scientists to Create Unlimited Blood Supply From Embryonic Stem Cells
3/23/2009 9:09:00 AM
Imagine ending the need for blood drives.
UK teams at NHS Blood and Transplant, the Scottish National Blood Transfusion Service and the Wellcome Trust, the world's biggest medical research charity, may do just that.
These scientists are working on becoming the world's first producers of unlimited amounts of artificial human blood from embryonic stem cells for blood transfusions.<...
Editors
Deal: Stem Cells Inc. Diversifies with Embryonic Stem Cell Acquisition
3/6/2009 8:40:00 AM
US based Stem Cells, Inc. (StemCells) acquires UK and Australia based Stem Cell Sciences plc in $5 million stock and cash deal.
This is StemCells's gambit to diversify from being solely an adult stem cell business into being a global provider of embryonic stem cells, induced stem cells (artificial embryonic), and adult stem cells.
Editors
Breakthrough: Can Stop Embryonic Stem Cells From Specializing
2/11/2009 3:20:00 PM
UK scientists have identified a chemical that will stop an embryonic stem cell from differentiating for several weeks so it is possible to can grow large numbers of them before they change into other cell types.